|
Company:
|
GUARDANT HEALTH, INC. (GH)
|
|
Form Type:
|
4
|
|
Filing Date:
|
1/13/2021
|
|
CIK:
|
0001576280
|
|
Address:
|
505 PENOBSCOT DR.
|
|
City, State, Zip:
|
REDWOOD CITY, California 94063
|
|
Telephone:
|
855-698-8887
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$159.94
|
Change:
0.65 (0.41%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$15.99B
|
|
|
|
|
|
|
Description of Business
|
|
We are a leading precision oncology company focused on helping conquer cancer
globally through use of our proprietary blood-based tests, vast data sets and
advanced analytics. We believe that the key to conquering cancer is
unprecedented access to its molecular information throughout all stages of the
disease, which we intend to enable by a routine blood draw, or liquid biopsy.
Our Guardant Health Oncology Platform is designed to leverage our capabilities
in technology, clinical development, regulatory and reimbursement to drive
commercial adoption of our tests, improve patient clinical outcomes, lower
healthcare costs and accelerate drug development. In pursuit of our goal to
manage cancer across all stages of the disease, we have launched our Guardant360
and GuardantOMNI tests for advanced stage cancer.
|
|
|
|